A group of South African hunter-gatherers is to receive six per cent of all royalties received by South Africa's leading research organisation from a potential anti-obesity drug derived from the local hoodia plant. Under the deal, the South African Council for Scientific and Industrial Research (CSIR) will also pay the San community eight per cent of all milestone payments received from Phytopharm, its UK-based licencee for the drug. The money will be used for the "general upliftment, development and training of the San community".